News Focus
News Focus
icon url

biomaven0

12/02/10 11:39 PM

#109859 RE: Biowatch #109858

I respect a Harvard law Degree.



Maybe not so much in this case - when I graduated in the mid-80's they didn't even offer a patent law course. Only IP course offered was copyright.

Teva lives and dies on patent infringement. They undoubtedly have the best talent of any biotech or pharma company by far. Of course their attorneys are going to have to do a 180 in terms of what side of validity and infringement they are on here...

Peter


icon url

10nisman

12/03/10 1:04 AM

#109860 RE: Biowatch #109858

Yes, impressive credentials, but TEVA's been around the block a few times regarding patent disputes. I respect a Harvard law Degree. Over and above that, he has excellent credentials. I respect what he's done, but what matters is what he can do for this case, and what his support staff can do to help.

NVS has been around the block a few times as well. IMHO, we can safely assume NVS/Sandoz will line-up a legal team equal to or better than Teva's. mLovenox is a very important for NVS/Sandoz and they will spend whatever is needed to support their position.

10nis